CLS (CLI) Rating Reiterated by Liberum Capital

Share on StockTwits

CLS (LON:CLI)‘s stock had its “buy” rating reissued by Liberum Capital in a report issued on Wednesday. They currently have a GBX 300 ($3.92) price target on the stock. Liberum Capital’s target price indicates a potential upside of 21.21% from the company’s current price.

Several other research analysts have also recently issued reports on CLI. Peel Hunt reaffirmed a “buy” rating on shares of CLS in a research report on Thursday, November 22nd. Berenberg Bank upped their price objective on CLS from GBX 265 ($3.46) to GBX 275 ($3.59) and gave the stock a “buy” rating in a research report on Friday, March 8th.

LON:CLI opened at GBX 247.50 ($3.23) on Wednesday. The stock has a market cap of $1.00 billion and a PE ratio of 8.11. CLS has a 1 year low of GBX 195 ($2.55) and a 1 year high of GBX 257 ($3.36). The company has a quick ratio of 0.65, a current ratio of 1.02 and a debt-to-equity ratio of 74.93.

In other news, insider Elizabeth Edwards bought 4,527 shares of CLS stock in a transaction dated Friday, December 21st. The stock was acquired at an average cost of GBX 219 ($2.86) per share, with a total value of £9,914.13 ($12,954.57).

CLS Company Profile

CLS Holdings plc, together with its subsidiaries, engages in the investment, management, and development of commercial properties in the United Kingdom, France, Germany, and Sweden. The company operates in two segments, Investment Property and Other Investments. It also invests in hotels, corporate bonds, shares, and other corporate investments.

Featured Story: Risk Tolerance

Receive News & Ratings for CLS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CLS and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply